At issue: whether opioid settlement money — paid by health care companies that were sued for fueling the opioid crisis and meant to help states abate addiction — should be funneled to two ...

Feb. 25, 2025 – The FDA has approved a new treatment plan for a long-acting injection, making it easier for people with moderate to severe opioid use disorder (OUD) to start and keep up with ...

The changes aim to shorten the time to achieve treatment effects in patients with opioid use disorder. The FDA has approved label changes for once-monthly Sublocade, helping to reduce possible ...

Could sex hormones explain the difference in opioid use and misuse between genders? Since 1999, the American opioid epidemic has killed more than half a million people, and according to the ...

Why hasn’t it been more widely adopted? A dose of buprenorphine, an opioid that can help treat addiction to more serious opioids like heroin and fentanyl, being dispensed at the Alameda Health ...

Preparation of a dose of Buprenorphine, an opioid that can be administered to people with opioid-use disorder to blunt cravings for other drugs like fentanyl and reduce the risk of overdose.Credit ...

RICHMOND, Va. (WRIC) — The U.S. Food and Drug Administration (FDA) has approved Journavx, the first opioid-free prescription drug for moderate to severe acute pain in more than 20 years.

PEOPLE RAVAGED BY THE OVERDOSE CRISIS. IN THE LAST TWO YEARS, MORE THAN 4000 PEOPLE HAVE DIED FROM OPIOID RELATED OVERDOSES IN MASSACHUSETTS. AND DURING THAT SAME TIME PERIOD, OUR CITIES AND TOWNS ...